Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Global Recombinant Monoclonal Antibody Market Growth 2024-2030

Report ID: 2991109 | Published Date: May 2025 | No. of Page: 93 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report

    1.1 Market Introduction

    1.2 Years Considered

    1.3 Research Objectives

    1.4 Market Research Methodology

    1.5 Research Process and Data Source

    1.6 Economic Indicators

    1.7 Currency Considered

    1.8 Market Estimation Caveats

2 Executive Summary

    2.1 World Market Overview

        2.1.1 Global Recombinant Monoclonal Antibody Annual Sales 2019-2030

        2.1.2 World Current & Future Analysis for Recombinant Monoclonal Antibody by Geographic Region, 2019, 2023 & 2030

        2.1.3 World Current & Future Analysis for Recombinant Monoclonal Antibody by Country/Region, 2019, 2023 & 2030

    2.2 Recombinant Monoclonal Antibody Segment by Type

        2.2.1 Humanized Antibodies

        2.2.2 Small Molecule Antibody

        2.2.3 Other

    2.3 Recombinant Monoclonal Antibody Sales by Type

        2.3.1 Global Recombinant Monoclonal Antibody Sales Market Share by Type (2019-2024)

        2.3.2 Global Recombinant Monoclonal Antibody Revenue and Market Share by Type (2019-2024)

        2.3.3 Global Recombinant Monoclonal Antibody Sale Price by Type (2019-2024)

    2.4 Recombinant Monoclonal Antibody Segment by Application

        2.4.1 Immunohistochemistry

        2.4.2 Western Blot

        2.4.3 Immunofluorescence

        2.4.4 Other

    2.5 Recombinant Monoclonal Antibody Sales by Application

        2.5.1 Global Recombinant Monoclonal Antibody Sale Market Share by Application (2019-2024)

        2.5.2 Global Recombinant Monoclonal Antibody Revenue and Market Share by Application (2019-2024)

        2.5.3 Global Recombinant Monoclonal Antibody Sale Price by Application (2019-2024)

3 Global Recombinant Monoclonal Antibody by Company

    3.1 Global Recombinant Monoclonal Antibody Breakdown Data by Company

        3.1.1 Global Recombinant Monoclonal Antibody Annual Sales by Company (2019-2024)

        3.1.2 Global Recombinant Monoclonal Antibody Sales Market Share by Company (2019-2024)

    3.2 Global Recombinant Monoclonal Antibody Annual Revenue by Company (2019-2024)

        3.2.1 Global Recombinant Monoclonal Antibody Revenue by Company (2019-2024)

        3.2.2 Global Recombinant Monoclonal Antibody Revenue Market Share by Company (2019-2024)

    3.3 Global Recombinant Monoclonal Antibody Sale Price by Company

    3.4 Key Manufacturers Recombinant Monoclonal Antibody Producing Area Distribution, Sales Area, Product Type

        3.4.1 Key Manufacturers Recombinant Monoclonal Antibody Product Location Distribution

        3.4.2 Players Recombinant Monoclonal Antibody Products Offered

    3.5 Market Concentration Rate Analysis

        3.5.1 Competition Landscape Analysis

        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    3.6 New Products and Potential Entrants

    3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Recombinant Monoclonal Antibody by Geographic Region

    4.1 World Historic Recombinant Monoclonal Antibody Market Size by Geographic Region (2019-2024)

        4.1.1 Global Recombinant Monoclonal Antibody Annual Sales by Geographic Region (2019-2024)

        4.1.2 Global Recombinant Monoclonal Antibody Annual Revenue by Geographic Region (2019-2024)

    4.2 World Historic Recombinant Monoclonal Antibody Market Size by Country/Region (2019-2024)

        4.2.1 Global Recombinant Monoclonal Antibody Annual Sales by Country/Region (2019-2024)

        4.2.2 Global Recombinant Monoclonal Antibody Annual Revenue by Country/Region (2019-2024)

    4.3 Americas Recombinant Monoclonal Antibody Sales Growth

    4.4 APAC Recombinant Monoclonal Antibody Sales Growth

    4.5 Europe Recombinant Monoclonal Antibody Sales Growth

    4.6 Middle East & Africa Recombinant Monoclonal Antibody Sales Growth

5 Americas

    5.1 Americas Recombinant Monoclonal Antibody Sales by Country

        5.1.1 Americas Recombinant Monoclonal Antibody Sales by Country (2019-2024)

        5.1.2 Americas Recombinant Monoclonal Antibody Revenue by Country (2019-2024)

    5.2 Americas Recombinant Monoclonal Antibody Sales by Type

    5.3 Americas Recombinant Monoclonal Antibody Sales by Application

    5.4 United States

    5.5 Canada

    5.6 Mexico

    5.7 Brazil

6 APAC

    6.1 APAC Recombinant Monoclonal Antibody Sales by Region

        6.1.1 APAC Recombinant Monoclonal Antibody Sales by Region (2019-2024)

        6.1.2 APAC Recombinant Monoclonal Antibody Revenue by Region (2019-2024)

    6.2 APAC Recombinant Monoclonal Antibody Sales by Type

    6.3 APAC Recombinant Monoclonal Antibody Sales by Application

    6.4 China

    6.5 Japan

    6.6 South Korea

    6.7 Southeast Asia

    6.8 India

    6.9 Australia

    6.10 China Taiwan

7 Europe

    7.1 Europe Recombinant Monoclonal Antibody by Country

        7.1.1 Europe Recombinant Monoclonal Antibody Sales by Country (2019-2024)

        7.1.2 Europe Recombinant Monoclonal Antibody Revenue by Country (2019-2024)

    7.2 Europe Recombinant Monoclonal Antibody Sales by Type

    7.3 Europe Recombinant Monoclonal Antibody Sales by Application

    7.4 Germany

    7.5 France

    7.6 UK

    7.7 Italy

    7.8 Russia

8 Middle East & Africa

    8.1 Middle East & Africa Recombinant Monoclonal Antibody by Country

        8.1.1 Middle East & Africa Recombinant Monoclonal Antibody Sales by Country (2019-2024)

        8.1.2 Middle East & Africa Recombinant Monoclonal Antibody Revenue by Country (2019-2024)

    8.2 Middle East & Africa Recombinant Monoclonal Antibody Sales by Type

    8.3 Middle East & Africa Recombinant Monoclonal Antibody Sales by Application

    8.4 Egypt

    8.5 South Africa

    8.6 Israel

    8.7 Turkey

    8.8 GCC Countries

9 Market Drivers, Challenges and Trends

    9.1 Market Drivers & Growth Opportunities

    9.2 Market Challenges & Risks

    9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

    10.1 Raw Material and Suppliers

    10.2 Manufacturing Cost Structure Analysis of Recombinant Monoclonal Antibody

    10.3 Manufacturing Process Analysis of Recombinant Monoclonal Antibody

    10.4 Industry Chain Structure of Recombinant Monoclonal Antibody

11 Marketing, Distributors and Customer

    11.1 Sales Channel

        11.1.1 Direct Channels

        11.1.2 Indirect Channels

    11.2 Recombinant Monoclonal Antibody Distributors

    11.3 Recombinant Monoclonal Antibody Customer

12 World Forecast Review for Recombinant Monoclonal Antibody by Geographic Region

    12.1 Global Recombinant Monoclonal Antibody Market Size Forecast by Region

        12.1.1 Global Recombinant Monoclonal Antibody Forecast by Region (2025-2030)

        12.1.2 Global Recombinant Monoclonal Antibody Annual Revenue Forecast by Region (2025-2030)

    12.2 Americas Forecast by Country

    12.3 APAC Forecast by Region

    12.4 Europe Forecast by Country

    12.5 Middle East & Africa Forecast by Country

    12.6 Global Recombinant Monoclonal Antibody Forecast by Type

    12.7 Global Recombinant Monoclonal Antibody Forecast by Application

13 Key Players Analysis

    13.1 Abcam

        13.1.1 Abcam Company Information

        13.1.2 Abcam Recombinant Monoclonal Antibody Product Portfolios and Specifications

        13.1.3 Abcam Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)

        13.1.4 Abcam Main Business Overview

        13.1.5 Abcam Latest Developments

    13.2 Boster Bio

        13.2.1 Boster Bio Company Information

        13.2.2 Boster Bio Recombinant Monoclonal Antibody Product Portfolios and Specifications

        13.2.3 Boster Bio Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)

        13.2.4 Boster Bio Main Business Overview

        13.2.5 Boster Bio Latest Developments

    13.3 Evitria

        13.3.1 Evitria Company Information

        13.3.2 Evitria Recombinant Monoclonal Antibody Product Portfolios and Specifications

        13.3.3 Evitria Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)

        13.3.4 Evitria Main Business Overview

        13.3.5 Evitria Latest Developments

    13.4 Novus Biologicals

        13.4.1 Novus Biologicals Company Information

        13.4.2 Novus Biologicals Recombinant Monoclonal Antibody Product Portfolios and Specifications

        13.4.3 Novus Biologicals Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)

        13.4.4 Novus Biologicals Main Business Overview

        13.4.5 Novus Biologicals Latest Developments

    13.5 ACROBiosystems

        13.5.1 ACROBiosystems Company Information

        13.5.2 ACROBiosystems Recombinant Monoclonal Antibody Product Portfolios and Specifications

        13.5.3 ACROBiosystems Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)

        13.5.4 ACROBiosystems Main Business Overview

        13.5.5 ACROBiosystems Latest Developments

    13.6 Abyntek Biopharma

        13.6.1 Abyntek Biopharma Company Information

        13.6.2 Abyntek Biopharma Recombinant Monoclonal Antibody Product Portfolios and Specifications

        13.6.3 Abyntek Biopharma Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)

        13.6.4 Abyntek Biopharma Main Business Overview

        13.6.5 Abyntek Biopharma Latest Developments

    13.7 Sino Biological

        13.7.1 Sino Biological Company Information

        13.7.2 Sino Biological Recombinant Monoclonal Antibody Product Portfolios and Specifications

        13.7.3 Sino Biological Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)

        13.7.4 Sino Biological Main Business Overview

        13.7.5 Sino Biological Latest Developments

    13.8 Enzo Life Sciences

        13.8.1 Enzo Life Sciences Company Information

        13.8.2 Enzo Life Sciences Recombinant Monoclonal Antibody Product Portfolios and Specifications

        13.8.3 Enzo Life Sciences Recombinant Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2019-2024)

        13.8.4 Enzo Life Sciences Main Business Overview

        13.8.5 Enzo Life Sciences Latest Developments

14 Research Findings and Conclusion


List of Tables

    Table 1. Recombinant Monoclonal Antibody Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)

    Table 2. Recombinant Monoclonal Antibody Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)

    Table 3. Major Players of Humanized Antibodies

    Table 4. Major Players of Small Molecule Antibody

    Table 5. Major Players of Other

    Table 6. Global Recombinant Monoclonal Antibody Sales by Type (2019-2024) & (K Units)

    Table 7. Global Recombinant Monoclonal Antibody Sales Market Share by Type (2019-2024)

    Table 8. Global Recombinant Monoclonal Antibody Revenue by Type (2019-2024) & ($ million)

    Table 9. Global Recombinant Monoclonal Antibody Revenue Market Share by Type (2019-2024)

    Table 10. Global Recombinant Monoclonal Antibody Sale Price by Type (2019-2024) & (US$/Unit)

    Table 11. Global Recombinant Monoclonal Antibody Sales by Application (2019-2024) & (K Units)

    Table 12. Global Recombinant Monoclonal Antibody Sales Market Share by Application (2019-2024)

    Table 13. Global Recombinant Monoclonal Antibody Revenue by Application (2019-2024)

    Table 14. Global Recombinant Monoclonal Antibody Revenue Market Share by Application (2019-2024)

    Table 15. Global Recombinant Monoclonal Antibody Sale Price by Application (2019-2024) & (US$/Unit)

    Table 16. Global Recombinant Monoclonal Antibody Sales by Company (2019-2024) & (K Units)

    Table 17. Global Recombinant Monoclonal Antibody Sales Market Share by Company (2019-2024)

    Table 18. Global Recombinant Monoclonal Antibody Revenue by Company (2019-2024) ($ Millions)

    Table 19. Global Recombinant Monoclonal Antibody Revenue Market Share by Company (2019-2024)

    Table 20. Global Recombinant Monoclonal Antibody Sale Price by Company (2019-2024) & (US$/Unit)

    Table 21. Key Manufacturers Recombinant Monoclonal Antibody Producing Area Distribution and Sales Area

    Table 22. Players Recombinant Monoclonal Antibody Products Offered

    Table 23. Recombinant Monoclonal Antibody Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)

    Table 24. New Products and Potential Entrants

    Table 25. Mergers & Acquisitions, Expansion

    Table 26. Global Recombinant Monoclonal Antibody Sales by Geographic Region (2019-2024) & (K Units)

    Table 27. Global Recombinant Monoclonal Antibody Sales Market Share Geographic Region (2019-2024)

    Table 28. Global Recombinant Monoclonal Antibody Revenue by Geographic Region (2019-2024) & ($ millions)

    Table 29. Global Recombinant Monoclonal Antibody Revenue Market Share by Geographic Region (2019-2024)

    Table 30. Global Recombinant Monoclonal Antibody Sales by Country/Region (2019-2024) & (K Units)

    Table 31. Global Recombinant Monoclonal Antibody Sales Market Share by Country/Region (2019-2024)

    Table 32. Global Recombinant Monoclonal Antibody Revenue by Country/Region (2019-2024) & ($ millions)

    Table 33. Global Recombinant Monoclonal Antibody Revenue Market Share by Country/Region (2019-2024)

    Table 34. Americas Recombinant Monoclonal Antibody Sales by Country (2019-2024) & (K Units)

    Table 35. Americas Recombinant Monoclonal Antibody Sales Market Share by Country (2019-2024)

    Table 36. Americas Recombinant Monoclonal Antibody Revenue by Country (2019-2024) & ($ Millions)

    Table 37. Americas Recombinant Monoclonal Antibody Revenue Market Share by Country (2019-2024)

    Table 38. Americas Recombinant Monoclonal Antibody Sales by Type (2019-2024) & (K Units)

    Table 39. Americas Recombinant Monoclonal Antibody Sales by Application (2019-2024) & (K Units)

    Table 40. APAC Recombinant Monoclonal Antibody Sales by Region (2019-2024) & (K Units)

    Table 41. APAC Recombinant Monoclonal Antibody Sales Market Share by Region (2019-2024)

    Table 42. APAC Recombinant Monoclonal Antibody Revenue by Region (2019-2024) & ($ Millions)

    Table 43. APAC Recombinant Monoclonal Antibody Revenue Market Share by Region (2019-2024)

    Table 44. APAC Recombinant Monoclonal Antibody Sales by Type (2019-2024) & (K Units)

    Table 45. APAC Recombinant Monoclonal Antibody Sales by Application (2019-2024) & (K Units)

    Table 46. Europe Recombinant Monoclonal Antibody Sales by Country (2019-2024) & (K Units)

    Table 47. Europe Recombinant Monoclonal Antibody Sales Market Share by Country (2019-2024)

    Table 48. Europe Recombinant Monoclonal Antibody Revenue by Country (2019-2024) & ($ Millions)

    Table 49. Europe Recombinant Monoclonal Antibody Revenue Market Share by Country (2019-2024)

    Table 50. Europe Recombinant Monoclonal Antibody Sales by Type (2019-2024) & (K Units)

    Table 51. Europe Recombinant Monoclonal Antibody Sales by Application (2019-2024) & (K Units)

    Table 52. Middle East & Africa Recombinant Monoclonal Antibody Sales by Country (2019-2024) & (K Units)

    Table 53. Middle East & Africa Recombinant Monoclonal Antibody Sales Market Share by Country (2019-2024)

    Table 54. Middle East & Africa Recombinant Monoclonal Antibody Revenue by Country (2019-2024) & ($ Millions)

    Table 55. Middle East & Africa Recombinant Monoclonal Antibody Revenue Market Share by Country (2019-2024)

    Table 56. Middle East & Africa Recombinant Monoclonal Antibody Sales by Type (2019-2024) & (K Units)

    Table 57. Middle East & Africa Recombinant Monoclonal Antibody Sales by Application (2019-2024) & (K Units)

    Table 58. Key Market Drivers & Growth Opportunities of Recombinant Monoclonal Antibody

    Table 59. Key Market Challenges & Risks of Recombinant Monoclonal Antibody

    Table 60. Key Industry Trends of Recombinant Monoclonal Antibody

    Table 61. Recombinant Monoclonal Antibody Raw Material

    Table 62. Key Suppliers of Raw Materials

    Table 63. Recombinant Monoclonal Antibody Distributors List

    Table 64. Recombinant Monoclonal Antibody Customer List

    Table 65. Global Recombinant Monoclonal Antibody Sales Forecast by Region (2025-2030) & (K Units)

    Table 66. Global Recombinant Monoclonal Antibody Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 67. Americas Recombinant Monoclonal Antibody Sales Forecast by Country (2025-2030) & (K Units)

    Table 68. Americas Recombinant Monoclonal Antibody Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 69. APAC Recombinant Monoclonal Antibody Sales Forecast by Region (2025-2030) & (K Units)

    Table 70. APAC Recombinant Monoclonal Antibody Revenue Forecast by Region (2025-2030) & ($ millions)

    Table 71. Europe Recombinant Monoclonal Antibody Sales Forecast by Country (2025-2030) & (K Units)

    Table 72. Europe Recombinant Monoclonal Antibody Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 73. Middle East & Africa Recombinant Monoclonal Antibody Sales Forecast by Country (2025-2030) & (K Units)

    Table 74. Middle East & Africa Recombinant Monoclonal Antibody Revenue Forecast by Country (2025-2030) & ($ millions)

    Table 75. Global Recombinant Monoclonal Antibody Sales Forecast by Type (2025-2030) & (K Units)

    Table 76. Global Recombinant Monoclonal Antibody Revenue Forecast by Type (2025-2030) & ($ Millions)

    Table 77. Global Recombinant Monoclonal Antibody Sales Forecast by Application (2025-2030) & (K Units)

    Table 78. Global Recombinant Monoclonal Antibody Revenue Forecast by Application (2025-2030) & ($ Millions)

    Table 79. Abcam Basic Information, Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

    Table 80. Abcam Recombinant Monoclonal Antibody Product Portfolios and Specifications

    Table 81. Abcam Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 82. Abcam Main Business

    Table 83. Abcam Latest Developments

    Table 84. Boster Bio Basic Information, Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

    Table 85. Boster Bio Recombinant Monoclonal Antibody Product Portfolios and Specifications

    Table 86. Boster Bio Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 87. Boster Bio Main Business

    Table 88. Boster Bio Latest Developments

    Table 89. Evitria Basic Information, Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

    Table 90. Evitria Recombinant Monoclonal Antibody Product Portfolios and Specifications

    Table 91. Evitria Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 92. Evitria Main Business

    Table 93. Evitria Latest Developments

    Table 94. Novus Biologicals Basic Information, Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

    Table 95. Novus Biologicals Recombinant Monoclonal Antibody Product Portfolios and Specifications

    Table 96. Novus Biologicals Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 97. Novus Biologicals Main Business

    Table 98. Novus Biologicals Latest Developments

    Table 99. ACROBiosystems Basic Information, Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

    Table 100. ACROBiosystems Recombinant Monoclonal Antibody Product Portfolios and Specifications

    Table 101. ACROBiosystems Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 102. ACROBiosystems Main Business

    Table 103. ACROBiosystems Latest Developments

    Table 104. Abyntek Biopharma Basic Information, Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

    Table 105. Abyntek Biopharma Recombinant Monoclonal Antibody Product Portfolios and Specifications

    Table 106. Abyntek Biopharma Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 107. Abyntek Biopharma Main Business

    Table 108. Abyntek Biopharma Latest Developments

    Table 109. Sino Biological Basic Information, Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

    Table 110. Sino Biological Recombinant Monoclonal Antibody Product Portfolios and Specifications

    Table 111. Sino Biological Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 112. Sino Biological Main Business

    Table 113. Sino Biological Latest Developments

    Table 114. Enzo Life Sciences Basic Information, Recombinant Monoclonal Antibody Manufacturing Base, Sales Area and Its Competitors

    Table 115. Enzo Life Sciences Recombinant Monoclonal Antibody Product Portfolios and Specifications

    Table 116. Enzo Life Sciences Recombinant Monoclonal Antibody Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2019-2024)

    Table 117. Enzo Life Sciences Main Business

    Table 118. Enzo Life Sciences Latest Developments

List of Figures

    Figure 1. Picture of Recombinant Monoclonal Antibody

    Figure 2. Recombinant Monoclonal Antibody Report Years Considered

    Figure 3. Research Objectives

    Figure 4. Research Methodology

    Figure 5. Research Process and Data Source

    Figure 6. Global Recombinant Monoclonal Antibody Sales Growth Rate 2019-2030 (K Units)

    Figure 7. Global Recombinant Monoclonal Antibody Revenue Growth Rate 2019-2030 ($ Millions)

    Figure 8. Recombinant Monoclonal Antibody Sales by Region (2019, 2023 & 2030) & ($ Millions)

    Figure 9. Product Picture of Humanized Antibodies

    Figure 10. Product Picture of Small Molecule Antibody

    Figure 11. Product Picture of Other

    Figure 12. Global Recombinant Monoclonal Antibody Sales Market Share by Type in 2023

    Figure 13. Global Recombinant Monoclonal Antibody Revenue Market Share by Type (2019-2024)

    Figure 14. Recombinant Monoclonal Antibody Consumed in Immunohistochemistry

    Figure 15. Global Recombinant Monoclonal Antibody Market: Immunohistochemistry (2019-2024) & (K Units)

    Figure 16. Recombinant Monoclonal Antibody Consumed in Western Blot

    Figure 17. Global Recombinant Monoclonal Antibody Market: Western Blot (2019-2024) & (K Units)

    Figure 18. Recombinant Monoclonal Antibody Consumed in Immunofluorescence

    Figure 19. Global Recombinant Monoclonal Antibody Market: Immunofluorescence (2019-2024) & (K Units)

    Figure 20. Recombinant Monoclonal Antibody Consumed in Other

    Figure 21. Global Recombinant Monoclonal Antibody Market: Other (2019-2024) & (K Units)

    Figure 22. Global Recombinant Monoclonal Antibody Sales Market Share by Application (2023)

    Figure 23. Global Recombinant Monoclonal Antibody Revenue Market Share by Application in 2023

    Figure 24. Recombinant Monoclonal Antibody Sales Market by Company in 2023 (K Units)

    Figure 25. Global Recombinant Monoclonal Antibody Sales Market Share by Company in 2023

    Figure 26. Recombinant Monoclonal Antibody Revenue Market by Company in 2023 ($ Million)

    Figure 27. Global Recombinant Monoclonal Antibody Revenue Market Share by Company in 2023

    Figure 28. Global Recombinant Monoclonal Antibody Sales Market Share by Geographic Region (2019-2024)

    Figure 29. Global Recombinant Monoclonal Antibody Revenue Market Share by Geographic Region in 2023

    Figure 30. Americas Recombinant Monoclonal Antibody Sales 2019-2024 (K Units)

    Figure 31. Americas Recombinant Monoclonal Antibody Revenue 2019-2024 ($ Millions)

    Figure 32. APAC Recombinant Monoclonal Antibody Sales 2019-2024 (K Units)

    Figure 33. APAC Recombinant Monoclonal Antibody Revenue 2019-2024 ($ Millions)

    Figure 34. Europe Recombinant Monoclonal Antibody Sales 2019-2024 (K Units)

    Figure 35. Europe Recombinant Monoclonal Antibody Revenue 2019-2024 ($ Millions)

    Figure 36. Middle East & Africa Recombinant Monoclonal Antibody Sales 2019-2024 (K Units)

    Figure 37. Middle East & Africa Recombinant Monoclonal Antibody Revenue 2019-2024 ($ Millions)

    Figure 38. Americas Recombinant Monoclonal Antibody Sales Market Share by Country in 2023

    Figure 39. Americas Recombinant Monoclonal Antibody Revenue Market Share by Country in 2023

    Figure 40. Americas Recombinant Monoclonal Antibody Sales Market Share by Type (2019-2024)

    Figure 41. Americas Recombinant Monoclonal Antibody Sales Market Share by Application (2019-2024)

    Figure 42. United States Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 43. Canada Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 44. Mexico Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 45. Brazil Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 46. APAC Recombinant Monoclonal Antibody Sales Market Share by Region in 2023

    Figure 47. APAC Recombinant Monoclonal Antibody Revenue Market Share by Regions in 2023

    Figure 48. APAC Recombinant Monoclonal Antibody Sales Market Share by Type (2019-2024)

    Figure 49. APAC Recombinant Monoclonal Antibody Sales Market Share by Application (2019-2024)

    Figure 50. China Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 51. Japan Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 52. South Korea Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 53. Southeast Asia Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 54. India Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 55. Australia Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 56. China Taiwan Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 57. Europe Recombinant Monoclonal Antibody Sales Market Share by Country in 2023

    Figure 58. Europe Recombinant Monoclonal Antibody Revenue Market Share by Country in 2023

    Figure 59. Europe Recombinant Monoclonal Antibody Sales Market Share by Type (2019-2024)

    Figure 60. Europe Recombinant Monoclonal Antibody Sales Market Share by Application (2019-2024)

    Figure 61. Germany Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 62. France Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 63. UK Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 64. Italy Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 65. Russia Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 66. Middle East & Africa Recombinant Monoclonal Antibody Sales Market Share by Country in 2023

    Figure 67. Middle East & Africa Recombinant Monoclonal Antibody Revenue Market Share by Country in 2023

    Figure 68. Middle East & Africa Recombinant Monoclonal Antibody Sales Market Share by Type (2019-2024)

    Figure 69. Middle East & Africa Recombinant Monoclonal Antibody Sales Market Share by Application (2019-2024)

    Figure 70. Egypt Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 71. South Africa Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 72. Israel Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 73. Turkey Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 74. GCC Country Recombinant Monoclonal Antibody Revenue Growth 2019-2024 ($ Millions)

    Figure 75. Manufacturing Cost Structure Analysis of Recombinant Monoclonal Antibody in 2023

    Figure 76. Manufacturing Process Analysis of Recombinant Monoclonal Antibody

    Figure 77. Industry Chain Structure of Recombinant Monoclonal Antibody

    Figure 78. Channels of Distribution

    Figure 79. Global Recombinant Monoclonal Antibody Sales Market Forecast by Region (2025-2030)

    Figure 80. Global Recombinant Monoclonal Antibody Revenue Market Share Forecast by Region (2025-2030)

    Figure 81. Global Recombinant Monoclonal Antibody Sales Market Share Forecast by Type (2025-2030)

    Figure 82. Global Recombinant Monoclonal Antibody Revenue Market Share Forecast by Type (2025-2030)

    Figure 83. Global Recombinant Monoclonal Antibody Sales Market Share Forecast by Application (2025-2030)

    Figure 84. Global Recombinant Monoclonal Antibody Revenue Market Share Forecast by Application (2025-2030)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abcam|||Boster Bio|||Evitria|||Novus Biologicals|||ACROBiosystems|||Abyntek Biopharma|||Sino Biological|||Enzo Life Sciences
Frequently Asked Questions
Recombinant Monoclonal Antibody report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Recombinant Monoclonal Antibody report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Recombinant Monoclonal Antibody report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports